PATENT CLAIM ANALYSIS

Application Number: 16041167
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["424", "208100"]

Abstract:
Methods for inducing safe and effective immune response against multiple clades of Human Immunodeficiency Virus (HIV) infection in human subjects are described. The methods involve heterologous vaccine combinations of adenovirus serotype 26 expression vectors expressing at least three mosaic HIV antigens with at least one isolated HIV gp140 protein.

Claim (Index 15):
The method according to  claim 1 , wherein the safe and effective immune response comprises a persistent humoral immune response against HIV envelope glycoprotein from at least Clade C at a response rate of at least 90% at 48 weeks after the last administration of the boosting compositions.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 95.0
- Lexical Diversity: 1.12766
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15968834', '14863808', '15693650', '15380123', '13130018']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7407721362820456
- 35 USC 102 Novelty (BERT): 0.6039364936067364
- Combined Prediction Score: 0.7270885720145147
- Mean Citation Score: 472.678518
- Max Citation Score: 600.1256
- Similarity Product: 427.345021644783

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test